AurorA Science

AurorA Science is a biotech investment company providing financial and industrial expertise to entrepreneurial start-ups with high therapeutic potential. It integrates an innovative research and development approach, supporting final pre-clinical and early clinical developments. The firm leverages in-house R&D facilities and specialized knowledge from its strategic industrial partners.

Founded in 2020, AurorA Science originated from a strategic partnership between technology transfer firm AurorA-TT and industrial investors Rottapharm Biotech and Italfarmaco. This collaboration stemmed from the insight to bridge academic discovery with industrial application, establishing an integrated framework for biotech innovation. Key individuals Edoardo Negroni and Pierluigi Paracchi are central to the firm's strategic development.

AurorA Science primarily serves entrepreneurial biotech start-ups developing novel therapeutic solutions. Its vision is to cultivate these portfolio companies through critical pre-clinical and early clinical stages, fostering growth towards successful partnerships with larger biopharma entities. This approach accelerates new therapies to market by facilitating optimal investment exits.